EA200000977A1 - Композиции пароксетина - Google Patents

Композиции пароксетина

Info

Publication number
EA200000977A1
EA200000977A1 EA200000977A EA200000977A EA200000977A1 EA 200000977 A1 EA200000977 A1 EA 200000977A1 EA 200000977 A EA200000977 A EA 200000977A EA 200000977 A EA200000977 A EA 200000977A EA 200000977 A1 EA200000977 A1 EA 200000977A1
Authority
EA
Eurasian Patent Office
Prior art keywords
paroxetine
compositions
depression
therapy
carrier
Prior art date
Application number
EA200000977A
Other languages
English (en)
Other versions
EA003393B1 (ru
Inventor
Эндрю Симон Крэйг
Нил Уорд
Original Assignee
Смитклайн Бичам Плс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам Плс filed Critical Смитклайн Бичам Плс
Publication of EA200000977A1 publication Critical patent/EA200000977A1/ru
Publication of EA003393B1 publication Critical patent/EA003393B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Abstract

Настоящее изобретение относится к пароксетину, адсорбированному на носителе с получением свободнотекучего порошка, используемого для заполнения капсул или получения таблеток; и применению его в терапии для лечения депрессии.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000977A 1998-03-24 1999-03-24 Композиции пароксетина EA003393B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations
PCT/GB1999/000922 WO1999048499A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions

Publications (2)

Publication Number Publication Date
EA200000977A1 true EA200000977A1 (ru) 2001-02-26
EA003393B1 EA003393B1 (ru) 2003-04-24

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000977A EA003393B1 (ru) 1998-03-24 1999-03-24 Композиции пароксетина

Country Status (20)

Country Link
EP (1) EP1063993A1 (ru)
JP (1) JP2002507569A (ru)
CN (1) CN1125639C (ru)
AP (1) AP2000001914A0 (ru)
AU (1) AU754765B2 (ru)
BG (1) BG104865A (ru)
BR (1) BR9908991A (ru)
CA (1) CA2324612A1 (ru)
EA (1) EA003393B1 (ru)
GB (1) GB9806312D0 (ru)
HU (1) HUP0101326A3 (ru)
ID (1) ID26485A (ru)
IL (1) IL138478A0 (ru)
NO (1) NO313404B1 (ru)
NZ (1) NZ506893A (ru)
PL (1) PL343095A1 (ru)
SK (1) SK14102000A3 (ru)
TR (1) TR200002750T2 (ru)
WO (1) WO1999048499A1 (ru)
ZA (1) ZA200005697B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (da) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
MXPA06000111A (es) * 2003-07-02 2006-04-27 Abbott Lab Proceso para preparar formulaciones de farmacos que regulan lipidos.
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
NO313404B1 (no) 2002-09-30
NO20004740L (no) 2000-10-03
EA003393B1 (ru) 2003-04-24
SK14102000A3 (sk) 2001-03-12
HUP0101326A2 (hu) 2002-05-29
BR9908991A (pt) 2000-12-12
CN1125639C (zh) 2003-10-29
IL138478A0 (en) 2001-10-31
GB9806312D0 (en) 1998-05-20
ZA200005697B (en) 2001-10-02
BG104865A (en) 2001-05-31
AU754765B2 (en) 2002-11-21
HUP0101326A3 (en) 2002-06-28
CN1294512A (zh) 2001-05-09
ID26485A (id) 2001-01-11
CA2324612A1 (en) 1999-09-30
AP2000001914A0 (en) 2000-09-30
NZ506893A (en) 2003-06-30
JP2002507569A (ja) 2002-03-12
TR200002750T2 (tr) 2000-12-21
PL343095A1 (en) 2001-07-30
WO1999048499A1 (en) 1999-09-30
NO20004740D0 (no) 2000-09-22
AU3045199A (en) 1999-10-18
EP1063993A1 (en) 2001-01-03

Similar Documents

Publication Publication Date Title
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
SE9704546D0 (sv) Novel compounds
ATE429210T1 (de) Orale flüssige zusammensetzungen
HUP0100950A3 (en) Cyclic amino compounds, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
BR0215281A (pt) Compostos de succinimida heterocìclicos fundidos e seus análogos, moduladores da função do receptor de hormÈnio nuclear
PT1319007E (pt) Compostos de succinimida heterociclicos fundidos e seus analogos enquanto moduladores da funcao dos receptores hormonais nucleares
MY136520A (en) Novel compounds
EE02962B1 (et) Mometasoonfuroaadi monohüdraat, selle valmistamismeetod ja farmatseutilised kompositsioonid
ATE433756T1 (de) Gelierte zusammensetzungen
ATE420880T1 (de) Kondensierte zyklische modulatoren der funktion von nuklearen hormonrezeptoren
SE9901875D0 (sv) Novel compounds
AU2002364082A8 (en) Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
EA200301275A1 (ru) Капсулы для ингаляции
ATE312080T1 (de) 2-chinolonen enthaltende arzneimittel
EA200500388A1 (ru) Способ получения сухих порошковых композиций для ингаляции
ES2173858T3 (es) Analogos de huperzina a.
YU13301A (sh) Muskarinski agonisti i antagonisti
EA200000977A1 (ru) Композиции пароксетина
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
EE200200252A (et) Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks
ATE280588T1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
EA200100098A1 (ru) Соли пароксетина
MXPA02012015A (es) Ligandos de receptores para integrinas.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU